Leslie Williams

First‐in‐human, double‐blind, placebo‐controlled, single‐dose escalation study of aducanumab (BIIB037) in mild‐to‐moderate Alzheimer's disease

J L Ferrero, Leslie Williams, Heather Stella et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2016 · 181 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Gautam Goel, Tim King, A. James M. Daveson et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 144 citations · Full text

Life Sciences, Immunology, Autoimmunity +16

Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease

Gautam Goel, A. James M. Daveson, C E Hooi et al. · Clinical & Experimental Immunology · 2019 · 74 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

A. James M. Daveson, Hooi C. Ee, Jane M. Andrews et al. · EBioMedicine · 2017 · 64 citations · Full text

Life Sciences, Immunology, Pharmacokinetics +17

Immunization of Rh‐Negative Volunteers by Repeated Injections of Very Small Amounts of Rh‐Positive Blood

Rachel Jakobowicz, Leslie Williams, Freda Silberman · Vox Sanguinis · 1972 · 61 citations

Veterinary Medicine, Immunology, Immunization +5